Generic Nasonex Nasal Spray Approved — Physician’s First Watch

Medical News |
March 23, 2016

Generic Nasonex Nasal Spray Approved

By Kristin J. Kelley

Edited by David G. Fairchild, MD, MPH

The first generic version of mometasone furoate monohydrate (Nasonex nasal spray) has been approved by the FDA, according to the drug's manufacturer.

The nasal spray is used to treat allergy symptoms (seasonal and perennial allergic rhinitis) in adults and children aged 2 years and older and nasal polyps in adults. It is also approved to prevent seasonal allergies in patients 12 years and older.

Patients with vision problems, tuberculosis, or recent nasal injury, sores, or surgery, should disclose these conditions to a healthcare provider before using the nasal spray. See the prescribing label for further cautions.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
Last load event
Format: 2016-07-29 17:55:07
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.